Finasteride Shedding and Timeline: What to Expect
This is a research-based fact check, not medical advice. The findings summarized here come from peer-reviewed studies and are presented without added opinions. Consult a certified healthcare practitioner before making any treatment decision.
Verdict
Finasteride-related shedding can occur in the first 1-3 months of treatment and represents hair follicles entering a new growth cycle, not treatment failure. Visible improvement typically begins at 3-6 months. Maximum results are usually seen at 12-24 months. Clinical improvement was observed as early as 3 months in the FDA pivotal trials, with continued improvement through 2 years. Hair loss resumes within approximately 12 months of stopping finasteride.
Key takeaways
- Finasteride shedding can occur in months 1-3 and is a recognised part of the treatment cycle.
- Shedding is not a sign the drug is failing it reflects hair follicles entering a new growth phase.
- Visible improvement typically begins at 3-6 months.
- Maximum results are usually seen at 12-24 months of consistent use.
- Stopping finasteride causes hair loss to resume within approximately 12 months.
- If no improvement is seen by 12 months, the treatment may not be effective for that individual.
Finasteride shedding
A subset of men starting finasteride experience increased hair shedding in the first 1-3 months. This is referred to as a telogen effluvium and occurs when finasteride reduces DHT levels, prompting hair follicles that have been miniaturised or in an extended resting phase to shift into a new growth cycle. Hairs in the telogen (resting) phase shed before new anagen (growth) hairs emerge. This is similar to the shedding that occurs with topical minoxidil. Full guidance on finasteride including efficacy data is in our finasteride efficacy guide and broader treatment options are covered in the hair restoration guide.
Finasteride shedding is typically temporary. It generally resolves within a few weeks to months and is followed by the regrowth phase. Stopping finasteride during this period is counterproductive. However, it is worth noting that similar shedding rates have been observed in placebo groups in some trials, which complicates interpretation of individual cases.
The treatment timeline
Months 1-3: adjustment and shedding
The initial period involves the drug reducing DHT levels (typically by 60-70% in scalp tissue). Some men experience shedding; others notice no change. This is the period when patients are most likely to doubt the treatment and discontinue prematurely.
Months 3-6: early visible improvement
Clinical improvement was observed as early as 3 months in the FDA pivotal trials. By 6 months, most men who will respond to finasteride will see some measurable improvement in hair count or density, though this may not yet be obvious in everyday assessment.
Months 6-24: progressive improvement
The most significant improvements accumulate between 6 and 24 months. The FDA trial data showed continued improvement in hair count and weight between the 1-year and 2-year assessments. This continued improvement with extended use distinguishes finasteride from treatments that plateau earlier.
After 24 months: maintenance
Beyond 2 years, finasteride primarily acts as a maintenance treatment, slowing further progression of hair loss. The 5-year data showed that men on finasteride had significantly less hair loss progression compared to the placebo group, which continued to lose hair over this period.
What happens when you stop
When finasteride is discontinued, DHT levels return to baseline within weeks. Hair loss then resumes at its natural rate. In most men, the hair regained on finasteride is lost within 12 months of stopping, as miniaturisation progresses again. The drug does not accelerate hair loss beyond the normal trajectory after stopping.
When to reassess
If no visible improvement has occurred by 12 months of consistent use, it is reasonable to discuss alternatives with a dermatologist. Response rates in clinical trials were high but not universal. Approximately 16% of men did not respond to 1mg finasteride in the pivotal trial. Baseline photography is the most reliable way to assess progress.
Evidence at a glance
| Study | Patients | Key finding |
|---|---|---|
| Mella 2010: oral finasteride for pattern hair loss systematic review | Multiple RCTs | Clinical improvement from 3 months. Continued improvement at 24 months. 5-year data shows maintained benefit. |
What the research cannot tell you
- What proportion of men experience significant shedding vs no shedding in the first months. Trial data does not consistently report this.
- Whether the shedding phase in finasteride users is meaningfully different from shedding in placebo groups.
- How quickly individual men will see results, given wide variation in response timing.
- Whether stopping finasteride and restarting produces the same results as continuous use.